PTI-808

· Proteostasis Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PTI-808, covering 2020-04-06 to 2020-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis [Phase 1, Phase 2]

See pricing